Intensity Therapeutics (INTS) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.36
-0.24
-0.12
0

Details

Expected EPS
-0.224
Actual EPS
-0.22
Surprise EPS
0
Surprise Percent
+1.79%

Description

Intensity Therapeutics (INTS) has reported earnings of -0.22 per share for Q1 2025.

0 Comments

Share your thoughts